540686 Stock Overview
Engages in manufactures and markets active pharmaceutical ingredient (API) products to India, Asia, Africa, the Americas, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Smruthi Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹117.85 |
| 52 Week High | ₹218.80 |
| 52 Week Low | ₹115.30 |
| Beta | 0.80 |
| 11 Month Change | -9.35% |
| 3 Month Change | -19.36% |
| 1 Year Change | -37.83% |
| 33 Year Change | -49.19% |
| 5 Year Change | 161.89% |
| Change since IPO | 103.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540686 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.0% | -0.2% | 0.3% |
| 1Y | -37.8% | 40.5% | 27.3% |
Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 540686 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 540686 volatility | |
|---|---|
| 540686 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540686 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540686's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 303 | Purushotham Eaga | www.smruthiorganics.com |
Smruthi Organics Limited engages in manufactures and markets active pharmaceutical ingredient (API) products to India, Asia, Africa, the Americas, and internationally. The company’s API products, include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, vildagliptin, teneligliptin, and dapagliflozin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; ticagrelor for anti-platelets; and anti - hypertension. It provides drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs.
Smruthi Organics Limited Fundamentals Summary
| 540686 fundamental statistics | |
|---|---|
| Market cap | ₹1.35b |
| Earnings (TTM) | -₹9.21m |
| Revenue (TTM) | ₹1.20b |
1.1x
P/S Ratio-146.5x
P/E RatioIs 540686 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540686 income statement (TTM) | |
|---|---|
| Revenue | ₹1.20b |
| Cost of Revenue | ₹661.53m |
| Gross Profit | ₹536.50m |
| Other Expenses | ₹545.71m |
| Earnings | -₹9.21m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.80 |
| Gross Margin | 44.78% |
| Net Profit Margin | -0.77% |
| Debt/Equity Ratio | 25.0% |
How did 540686 perform over the long term?
See historical performance and comparison